Xifin Pharmacy Solutions
Coverage of Xifin Pharmacy Solutions in the Nexus archive.
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
An FDA panel narrowly voted 8-6 to allow compounding pharmacies to produce BPC-157, a popular unapproved peptide promoted by influencers like Joe Rogan. The decision followed criticism from FDA scientists about the lack of evidence for its medical efficacy, while panel members included individuals with industry ties. Health Secretary Robert F. Kennedy Jr. supported the move, aiming to overturn Biden-era restrictions.
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
An FDA panel narrowly voted 8-6 to expand access to BPC-157, an unapproved peptide popular among wellness influencers like Joe Rogan, despite FDA scientists' concerns about its safety and efficacy. The panel included industry-connected experts, and the decision is part of a broader review of seven peptides for potential compounding pharmacy use.